IT NewsNews

HP appoints Emma Walmsley as new CEO

HP Inc. has appointed Emma Walmsley as CEO. The former GSK chief will take up the role on 4 January 2027, succeeding interim CEO Bruce Broussard. On the same date, Broussard will become chair of the board of directors, succeeding Chip Bergh.

Walmsley will take over from Broussard on 4 January 2027. He has led HP as interim CEO since February 2026 and will remain with the company afterwards as chair of the board of directors. In that role, he succeeds Bergh, who has held the position since 2017. HP is listed on the New York Stock Exchange and, according to the company, operates in more than 180 countries.

AI as a common thread

Broussard places the appointment in the context of the changes AI is bringing about in the technology sector. According to him, HP was looking for a leader who would build on the company’s history while setting a clear course. He points specifically to the shift of AI applications to the edge, which he says is creating new opportunities in a world where more and more devices are connected to one another. Broussard states that Walmsley has experience in leading large organisations and driving change.

Walmsley says she wants to work with the team to further develop the role HP plays in how people will work in the future. She sees opportunities for new growth in the rise of AI and wants to harness the creativity within the company to seize them. In doing so, she aims to create long-term value for customers, shareholders, partners and employees.

International selection process

According to Bergh, the appointment followed an international selection process. He says Walmsley stood out for her experience across different sectors and her ability to translate customer insights into growth opportunities. Bergh also highlights her leadership style, which in his view puts people at the centre and gives an important place to setting clear priorities.

He thanks Broussard for his role as interim CEO, which he says gave the board the room to carry out the selection process carefully. Bergh expects Broussard, as chair, to ensure continuity during the transition and in the years that follow.

Background in pharmaceuticals and consumer products

Walmsley was CEO of British biopharmaceutical company GSK from April 2017 to December 2025. HP states that during that period she led the company through a transformation and improved its results. Under her leadership, GSK shifted its strategic focus to specialty medicines and vaccines and spun off its consumer healthcare division.

She joined GSK in 2010 and became CEO of GSK Consumer Healthcare in 2015, two years before taking charge of the entire group. Before that, she spent seventeen years at L’OrĂ©al, where she was responsible for international consumer operations. Walmsley already has a long-standing connection with the technology sector: she has been a member of Microsoft’s board of directors for seven years.

Bergh steps down as chair

Bergh has been a member of HP’s board of directors since 2015 and its chair since 2017. He will remain in post until Broussard takes over the role on 4 January 2027. Broussard says that over the past nine years Bergh has played an important role in guiding HP through a period of major change, with a focus on corporate governance, capital allocation and long-term value creation.

This article was originally published in Dutch on MSP Business. Read the original →